Hospira, Inc. has entered an agreement to acquire an API manufacturing facility and an associated R&D facility from Orchid Chemicals & Pharmaceuticals Ltd., an Indian pharmaceutical company, for approximately $200 million. With the acquisition, the company aims to reduce costs, support the supply of key antibiotic products and the future development of APIs.   The 50,000 square meter facility in Aurangabad employs 640 chemists, engineers and technicians. The R&D facility based in Che...